الخميس 10 محرم 1448هـ
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
| عنوان الدراسة | داعم الدراسة | حالة الدراسة | دواء الدراسة | مرحلة الدراسة | رقم بروتوكول الدراسة | موقع الدراسة |
|---|---|---|---|---|---|---|
| A 26-week, Randomized, Double-blinded, Placebo controlled study to explore the Effects of Probiotics on Endotoxin Levels in patients with Type 2 Diabetes Mellitus | "Prince Mutaib bin Abdullah Chair for Biomarkers Research on Osteoporosis" | Completed | Probiotics | 3 | STRP-10 | King Khalid University Hospital (Riyadh), King Abdulaziz University Hospital (Riyadh), Minstery of Health |
| Alleviating Post Surgical Dental Pain | Julphar | Rejected | Profinal XP 400 mg F.C Tablet | 4 | 1/2010/PXP/JUL | N/A |
| "Prospective Observational Clinical Practice Study in the 1st LineManagement of mCRC with Erbitux ™ in combination with Chemotherapy" | Merck Serono | Rejected | ERBITUX | 4 | EMR062202_ | N/A |
| "A prospective, observational, non-randomized, European, multi-centerregistry, collecting REal-life information for the utilization of instantaneouswave-free ratio™ (iFR®) in Assessing coronary stenosis relevance in theMulti-vesseL disease patients population." | Volcano | Rejected | VOLCAO-iFR® | 4 | 2014-CV-00 | N/A |
| A Prospective, Longitudinal, Multinational, Observational Study to Describe Patterns of Care and Outcomes of Men who are at High Risk for Poor Clinical Outcomes after Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men with Castration-Resistant Prostate Cancer and Men with Metastatic Prostate Cancer at Initial Diagnosis |
Astellas |
Rejected | 4 | ONC-MA1001 |
N/A | |
| RETROSPECTIVE EPIDEMIOLOGY STUDY OF ALK REARRANGEMENT IN NON-SMALL CELL LUNG CANCER PATIENTS IN THE MIDDLE EAST & NORTH AFRICA | Pfizer | Rejected | - | 4 | A8081046 | N/A |
| "(LUMINOUS)Study to observe the effectiveness andsafety of ranibizumab through individualized patienttreatment and associated " | Novartis | Completed | Ranibizumab 10mg/ml (Lucentis) | 4 | RFB002A2406 | King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah), Prince Sultan Military Medical City (Riyadh) |
| An observational study to evaluate the effectiveness, safty and effect on health-related quality of life of treatment in routine practice (PERFORMS) | Novartis | Completed | Fingolimod | 4 | CFTY720D-MAX-TH-01 | King Fahad Medical City (Riyadh), King Fahad Specialist Hospital (Dammam), King Faisal Specialist Hospital and Research Center (Jeddah) |
| An observational, prospective, open-label to assess effectiveness, safety and tolerability of once-yearly treatment with zoledronic acid in osteoporotic patients in a real-world setting (AZURE). | Novartis | Completed | Zoledronic acid | 4 | CZOL446H-MAX-SA-01 | King Fahad University Hospital (Al-Khobar), King Khalid University Hospital (Riyadh) |
| A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of KB195 in Subjects with a Urea Cycle Disorder with Inadequate Control on Standard of Care | Kaleido Biosciences | Ongoing | KB195 | 2 | K020-218 | King Khalid University Hospital (Riyadh), King Abdulaziz Medical City NG (Riyadh) |
تاريخ آخر تحديث: 08/05/2025 بتمام الساعة 03:17 مساء بتوقيت المملكة العربية السعودية
لم يتم تقديم أي تقييمات لهذه الصفحة بعد.
التعليقات والاقتراحات
لأي استفسارات أو ملاحظات حول الخدمات الحكومية، يرجى تعبئة المعلومات المطلوبة.